Pharmaceutical Market Europe • February 2022 • 3
COMMENT
In this month’s issue, Meindert Boysen, deputy chief executive and director of the Centre for Health Technology Evaluation at NICE looks at ways that could help to achieve fairer and faster access to medicines in the NHS. The global pandemic has highlighted the need for health and care systems to be able to respond to evolving situations with speed, flexibility and agility and, as Meindert explains, the proposed changes will shape the UK marketplace by offering greater decision-making flexibility where it truly counts and builds on several initiatives in which NICE is already involved. Read more on page 18.
In our cover article this month, Danny Buckland explores the importance of charting patient pathways with precision for better healthcare. As Danny explains, making a healthcare system tick is like creating a Swiss watch – it requires patience, persistence and a sharp eye for detail. Read more on page 30.
Looking ahead, in our March issue we have a spotlight on diversity, equity and inclusion (DE&I) in the workplace. In 2022, there is a renewed focus on DE&I in the workplace. But for DE&I to be successful, businesses as a whole need to be actively engaged. Today’s workforce is looking for organisations that are transparent in their focus on delivering DE&I and such businesses will significantly benefit from a workforce that represents and can potentially better understand diverse and multicultural audiences.
If you would like to make your voice heard on this topic, please get in touch at sales@pmlive.com
I hope you enjoy this issue!
Iona Everson
Group Managing Editor
Keep up to date with the latest developments in the UK and global healthcare marketplace – sign up to daily or weekly news alerts and fortnightly or monthly bulletins on specific topics at www.pmlive.com/register
THE TEAM
Editorial:
Group Managing Editor
Iona Everson
Journalist/editorial assistant
Fleur Jeffries
Studio:
Executive Director
Karl Equi
Senior Designer
Peter May
Sales:
Business Director
Tara Lovegrove
EDITORIAL ADVISORY BOARD
Philip Atkinson
Founder of Hive-Logic, Lifescience Transformation
Uday Bose
Corporate vice president, head of global marketing oncology, Boehringer Ingelheim
Dr Luc Hermans
VP commercial planning and operations Europe, Asia, Middle East, Gilead Sciences
Stefan Janssens
President EMEA, Cegedim Dendrite
John Morris
Partner, KPMG
Paul Pay
Chief business development officer, Norgine
Mark Rothera
Chief executive officer, Orchard Therapeutics
Ian Talmage
Senior vice president, global marketing, general medicine, Bayer Pharmaceuticals
PUBLISHED BY
PMGroup
Mansard House, Church Road, Little Bookham, Surrey, KT23 3JG, UK
Tel: +44 (0)1372 414200
Fax: +44 (0)1372 414201
CONTACT US
General enquiries: info@pmlive.com
Editorial: editor@pmlive.com
Advertising: sales@pmlive.com
Subscriptions: subscriptions@pmlive.com
Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.
© 2022 PMGroup
All rights reserved. No part of this publication may be copied, reproduced, transmitted, photocopied, recorded or stored on any retrieval system without the prior written consent of the publishers.
The magazine is also available at the following subscription rates: £120 UK, £180 Europe, £210 RoW